Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moon Haeng Hur

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 1, 2024
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort studyHyunjae Shin, Seung Up Kim, Byeong Geun Song, et al.
Gut and Liver|January 8, 2025
A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity CrisisJeayeon Park, Goh Eun Chung, Yoosoo Chang, et al.
Clinical and Molecular Hepatology|May 17, 2023
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphomaJeayeon Park, Sung Won Chung, Yun Bin Lee, et al.
Journal of Medical Virology|June 28, 2024
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis BHyunjae Shin, Gyung Sun Lim, Jae Woong Yoon, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral TreatmentGoh Eun Chung, Ju Yeon Kim, Hyunjae Shin, et al.
Journal of Liver Cancer|January 21, 2024
Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosisJeayeon Park, Yun Bin Lee, Yunmi Ko, et al.
Clinical and Molecular Hepatology|May 10, 2024
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort studyMoon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, et al.
Hepatology (Baltimore, Md.)|March 11, 2024
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort studySung Won Chung, Hye-Sung Moon, Hyunjae Shin, et al.
Frontiers in Oncology|March 17, 2023
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patientsSung Won Chung, Heejin Cho, Hyunjae Shin, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trialHyunjae Shin, Youngsu Park, Byeong Geun Song, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 1, 2024
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort studyHyunjae Shin, Seung Up Kim, Byeong Geun Song, et al.
Gut and Liver|January 8, 2025
A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity CrisisJeayeon Park, Goh Eun Chung, Yoosoo Chang, et al.
Clinical and Molecular Hepatology|May 17, 2023
Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphomaJeayeon Park, Sung Won Chung, Yun Bin Lee, et al.
Journal of Medical Virology|June 28, 2024
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis BHyunjae Shin, Gyung Sun Lim, Jae Woong Yoon, et al.
Diagnostics (Basel, Switzerland)|July 27, 2022
Correlation between Results of Semi-Quantitative and Quantitative Tests for Hepatitis B Virus Surface Antigen among Patients Achieving Viral Suppression with Antiviral TreatmentGoh Eun Chung, Ju Yeon Kim, Hyunjae Shin, et al.
Journal of Liver Cancer|January 21, 2024
Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosisJeayeon Park, Yun Bin Lee, Yunmi Ko, et al.
Clinical and Molecular Hepatology|May 10, 2024
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort studyMoon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, et al.
Hepatology (Baltimore, Md.)|March 11, 2024
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort studySung Won Chung, Hye-Sung Moon, Hyunjae Shin, et al.
Frontiers in Oncology|March 17, 2023
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patientsSung Won Chung, Heejin Cho, Hyunjae Shin, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trialHyunjae Shin, Youngsu Park, Byeong Geun Song, et al.
Pageof 5